Jeremy L. Stigall - 31 Dec 2022 Form 5 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role: GM, Biologics & Drug Delivery
Signature: /s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Issuer symbol: CLPT
Transactions as of: 31 Dec 2022
Net transactions value: +$5,242
Form type: 5
Filing time: 30 Jan 2023, 13:04:40 UTC
Previous filing: 23 Aug 2022
Next filing: 23 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLPT	Common Stock	Other	$5,242	+728	+1.7%	$7.20	43,420	30 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.